Lisa Von Moltke
CIK 1808592 · View on SEC EDGAR ↗
Insider
First SEC filing: June 17, 2026 · Latest: June 17, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 33 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
33 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | MCRB | S 10b5-1 | 4,416 | $0.81 | $3,577 | 39,875 Direct | -9.97% | Disposed | -71.8% (price as of 2026-08-21) |
| Nov. 18, 2024 | MCRB | S 10b5-1 | 977 | $0.54 | $528 | 32,415 Direct | -2.93% | Disposed | -57.7% (price as of 2026-08-21) |
| Oct. 28, 2024 | MCRB | S 10b5-1 | 4,334 | $0.69 | $2,990 | 30,423 Direct | -12.47% | Disposed | -66.9% (price as of 2026-08-21) |
| Aug. 16, 2024 | MCRB | S 10b5-1 | 973 | $0.84 | $817 | 21,013 Direct | -4.43% | Disposed | -72.8% (price as of 2026-08-21) |
| May 15, 2024 | MCRB | S 10b5-1 | 939 | $0.94 | $883 | 19,017 Direct | -4.71% | Disposed | -75.7% (price as of 2026-08-21) |
| Feb. 16, 2024 | MCRB | S 10b5-1 | 4,400 | $1.08 | $4,752 | 16,988 Direct | -20.57% | Disposed | -78.8% (price as of 2026-08-21) |
| Oct. 30, 2023 | MCRB | S 10b5-1 | 4,232 | $1.35 | $5,713 | 9,513 Direct | -30.79% | Disposed | -83.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 15, 2026 | ZBIO | Stock Option (Right to Buy) | Common Stock (150,000) | $18.71 | June 15, 2036 | 150,000 | Acquired |
| April 15, 2025 | ZBIO | Stock Option (Right to Buy) | Common Stock (400,000) | $8.72 | April 14, 2035 | 400,000 | Acquired |
| Feb. 15, 2025 | MCRB | Restricted Stock Units | Common Stock (2,969) | — | — | 2,969 | Disposed |
| Feb. 15, 2025 | MCRB | Restricted Stock Units | Common Stock (8,907) | — | — | 8,907 | Disposed |
| Feb. 7, 2025 | MCRB | Stock Option (Right to Buy) | Common Stock (650,000) | $0.78 | Feb. 6, 2035 | 650,000 | Acquired |
| Nov. 15, 2024 | MCRB | Restricted Stock Units | Common Stock (2,969) | — | — | 2,969 | Disposed |
| Oct. 27, 2024 | MCRB | Restricted Stock Units | Common Stock (13,744) | — | — | 13,744 | Disposed |
| Aug. 15, 2024 | MCRB | Restricted Stock Units | Common Stock (2,969) | — | — | 2,969 | Disposed |
| June 4, 2024 | TVRD | Stock Option (Right to Buy) | Common Stock (195,000) | $0.66 | June 4, 2034 | 195,000 | Acquired |
| May 15, 2024 | MCRB | Restricted Stock Units | Common Stock (2,968) | — | — | 2,968 | Disposed |
| Feb. 15, 2024 | MCRB | Restricted Stock Units | Common Stock (11,875) | — | — | 11,875 | Disposed |
| Feb. 14, 2024 | MCRB | Restricted Stock Units | Common Stock (35,625) | — | — | 35,625 | Acquired |
| Feb. 14, 2024 | MCRB | Stock Option (Right to Buy) | Common Stock (287,905) | $1.10 | Feb. 13, 2034 | 287,905 | Acquired |
| Feb. 14, 2024 | MCRB | Stock Option (Right to Buy) | Common Stock (213,750) | $1.10 | Feb. 13, 2034 | 213,750 | Acquired |
| Oct. 27, 2023 | MCRB | Restricted Stock Units | Common Stock (13,745) | — | — | 13,745 | Disposed |
| June 1, 2023 | TVRD | Stock Option (Right to Buy) | Common Stock (44,961) | $3.09 | June 1, 2033 | 44,961 | Acquired |
| April 27, 2023 | MCRB | Restricted Stock Units | Common Stock (27,489) | — | — | 27,489 | Acquired |
| Feb. 3, 2023 | MCRB | Stock Option (Right to Buy) | Common Stock (95,000) | $5.50 | Feb. 2, 2033 | 95,000 | Acquired |
| Feb. 3, 2023 | MCRB | Restricted Stock Units | Common Stock (47,500) | — | — | 47,500 | Acquired |
| Jan. 2, 2023 | TVRD | Stock Option (Right to Buy) | Common Stock (45,841) | $10.74 | Jan. 2, 2033 | 45,841 | Acquired |
| Feb. 4, 2022 | MCRB | Stock Option (Right to Buy) | Common Stock (175,000) | $7.38 | Feb. 3, 2032 | 175,000 | Acquired |
| Feb. 4, 2021 | MCRB | Stock Option (Right to Buy) | Common Stock (110,000) | $26.34 | Feb. 3, 2031 | 110,000 | Acquired |
| April 6, 2020 | MCRB | Stock Option (Right to Buy) | Common Stock (325,000) | $3.32 | April 5, 2030 | 325,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $515,000 | — | — | — | $206,000 | — | $7,988 | $1,270,353 |
| 2023 | $515,000 | — | — | — | $201,880 | — | $8,269 | $1,571,141 |
| 2022 | $490,000 | — | — | — | $208,000 | — | $8,139 | $1,734,614 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.